InvestorsHub Logo
icon url

misiu143

01/16/19 4:50 PM

#33704 RE: BlackDoggie #33703

I agree that Leronlimab may be use with other treatment for CCR5 positive cancers , but Keytruda and other check point inhibitors might be the best with us , especially that side effects are autoimmune disorders and we know that Leronlimab is helping for those diseases .
If the same we will see in combination it will be great for patients, much less side effects.

Honestly when Leronlimab will be approve , I dont see Maraviroc to be use to much , now without competition is use rarely only.

So I think between other combinations with Leronlimab we may even see cure in some cancers ..

The sooner the better and of course we need to see interim results for TNBC.



icon url

misiu143

01/16/19 7:57 PM

#33714 RE: BlackDoggie #33703

I am just thinking ,
if Leronlimab will be preventing side effects of Keytruda (if) when given together , maybe they will decide to use together even with CCR5 negative cancers ,
just to prevent this very serious side effects ..

I will try to follow all this information very carefully .,
Very interesting imo !!!